Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 12, Issue 31, 2006, Pages 4966-4972

  Yao, Deng Fu ^a   Wu, Wei ^a   Yao, Min ^b   Qui, Li Wei ^a   Wu, Xin Hua ^a   Su, Xiao Qin ^a   Zou, Li ^a   Yao, Deng Bing ^a   Meng, Xian Yong ^a  

^a NANTONG UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Peripheral blood mononuclear cells; Telomerase; Telomeric repeat amplification protocol

Indexed keywords

ALPHA FETOPROTEIN; TELOMERASE;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME ISOLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRECANCER; PROGNOSIS; PROTEIN EXPRESSION; RAT; REFERENCE VALUE; RNA EXTRACTION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

EID: 33748335745     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i31.4966     Document Type: Article

References (36)

1. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001; 411: 390-395
2. Yao D, Jiang D, Huang Z, Lu J, Tao Q, Yu Z, Meng X. Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma. Cancer 2000; 88: 761-769
3. Orito E, Mizokami M. Hepatitis B virus genotypes and hepatocellular carcinoma in Japan. Intervirology 2003; 46: 408-412
4. Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002; 8: 385-392
5. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31: 339-346
6. Ijichi M, Takayama T, Matsumura M, Shiratori Y, Omata M, Makuuchi M. alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology 2002; 35: 853-860
7. Funaki NO, Tanaka J, Seto SI, Kasamatsu T, Kaido T, Imamura M. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology 1997; 25: 564-568
8. Lee CM, Hsu CY, Eng HL, Huang WS, Lu SN, Changchien CS, Chen CL, Cho CL. Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma. Hepatogastroenterology 2004; 51: 796-800
9. Mu J, Wei LX. Telomere and telomerase in oncology. Cell Res 2002; 12: 1-7
10. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB, Brooks MW, Kaneko S, Murakami S, DeCaprio JA, Weinberg RA, Stewart SA, Hahn WC. Telomerase maintains telomere structure in normal human cells. Cell 2003; 114: 241-253
11. Testorelli C. Telomerase and cancer. J Exp Clin Cancer Res 2003; 22: 165-169
12. Satyanarayana A, Manns MP, Rudolph KL. Telomeres and telomerase: a dual role in hepatocarcinogenesis. Hepatology 2004; 40: 276-283
13. Liu YC, Chen CJ, Wu HS, Chan DC, Yu JC, Yang AH, Cheng YL, Lee SC, Harn HJ. Telomerase and c-myc expression in hepatocellular carcinomas. Eur J Surg Oncol 2004; 30: 384-390
14. Yang BH, Ran ZG. The Liver Cancer Committee of Chinese Anticancer Association: Diagnostic criteria of primary hepatocellular carcinoma. Zhonghua Ganzangbing Zazhi 2000; 8: 135
15. Cui ZN, Wang JT, Tian GS. Chinese National Viral Hepatitis Meeting (1995, Beijing): Diagnosis standard for viral hepatitis. Zhonghua Neike Zazhi 1996; 35: 8-16
16. Park YM, Choi JY, Byun BH, Cho CH, Kim HS, Kim BS. Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis. Exp Mol Med 1998; 30: 35-40
17. Yao DF, Wu XH, Zhu Y, Shi GS, Dong ZZ, Yao DB, Wu W, Qiu LW, Meng XY. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2005; 4: 220-226
18. Dong ZZ, Yao DF, Yao DB, Wu XH, Wu W, Qiu LW, Jiang DR, Zhu JH, Meng XY. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma. World J Gastroenterol 2005; 11: 4655-4660
19. Liu SX, Sun WS, Cao YL, Ma CH, Han LH, Zhang LN, Wang ZG, Zhu FL. Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells. World J Gastroenterol 2004; 10: 366-370
20. Klingelhutz AJ. The roles of telomeres and telomerase in cellular immortalization and the development of cancer. Anticancer Res 1999; 19: 4823-4830
21. Yokota T, Suda T, Igarashi M, Kuroiwa T, Waguri N, Kawai H, Mita Y, Aoyagi Y. Telomere length variation and maintenance in hepatocarcinogenesis. Cancer 2003; 98: 110-118
22. Chen CJ, Kyo S, Liu YC, Cheng YL, Hsieh CB, Chan DC, Yu JC, Harn HJ. Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma. World J Gastroenterol 2004; 10: 638-642
23. Yang Y, Chen Y, Zhang C, Huang H, Weissman SM. Nucleolar localization of hTERT protein is associated with telomerase function. Exp Cell Res 2002; 277: 201-209
24. Konnikova L, Simeone MC, Kruger MM, Kotecki M, Cochran BH. Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells. Cancer Res 2005; 65: 6516-6520
25. Hahn WC, Meyerson M. Telomerase activation, cellular immortalization and cancer. Ann Med 2001; 33: 123-129
26. Takahashi S, Kitamoto M, Takaishi H, Aikata H, Kawakami Y, Nakanishi T, Shimamoto F, Tahara E, Tahara H, Ide T, Kajiyama G. Expression of telomerase component genes in hepatocellular carcinomas. Eur J Cancer 2000; 36: 496-502
27. Shimada M, Hasegawa H, Gion T, Utsunomiya T, Shirabe K, Takenaka K, Otsuka T, Maehara Y, Sugimachi K. The role of telomerase activity in hepatocellular carcinoma. Am J Gastroenterol 2000; 95: 748-752
28. Piao YF, He M, Shi Y, Tang TY. Relationship between microvessel density and telomerase activity in hepatocellular carcinoma. World J Gastroenterol 2004; 10: 2147-2149
29. Waguri N, Suda T, Nomoto M, Kawai H, Mita Y, Kuroiwa T, Igarashi M, Kobayashi M, Fukuhara Y, Aoyagi Y. Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation. Clin Cancer Res 2003; 9: 3004-3011
30. Tatsuma T, Goto S, Kitano S, Lin YC, Lee CM, Chen CL. Telomerase activity in peripheral blood for diagnosis of hepatoma. J Gastroenterol Hepatol 2000; 15: 1064-1070
31. Liu DY, Peng ZH, Qiu GQ, Zhou CZ. Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis. World J Gastroenterol 2003; 9: 1859-1862
32. Iizuka N, Mori N, Tamesa T, Tangoku A, Oka M. Telomerase activity and Nm23-H2 protein expression in hepatocellular carcinoma. Anticancer Res 2003; 23: 43-47
33. Oh BK Jo Chae K, Park C, Kim K, Jung Lee W, Han KH, Nyun Park Y. Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis. J Hepatol 2003; 39: 786-792
34. Farazi PA, Glickman J, Jiang S, Yu A, Rudolph KL, DePinho RA. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. Cancer Res 2003; 63: 5021-5027
35. Onishi T, Nouso K, Higashi T, Toshikuni N, Nakatsukasa H, Kobayashi Y, Uemura M, Yumoto E, Fujiwara K, Sato S, Nakamura S, Yokoyama J, Hanafusa T, Shiratori Y. Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma. J Gastroenterol Hepatol 2003; 18: 1168-1174
36. Miura N, Maeda Y, Kanbe T, Yazama H, Takeda Y, Sato R, Tsukamoto T, Sato E, Marumoto A, Harada T, Sano A, Kishimoto Y, Hirooka Y, Murawaki Y, Hasegawa J, Shiota G. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma. Clin Cancer Res 2005; 11: 3205-3209